Compare NXT & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NXT | COO |
|---|---|---|
| Founded | 2013 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6B | 15.5B |
| IPO Year | 2023 | N/A |
| Metric | NXT | COO |
|---|---|---|
| Price | $90.36 | $81.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 11 |
| Target Price | ★ $91.80 | $88.55 |
| AVG Volume (30 Days) | 2.1M | ★ 3.7M |
| Earning Date | 01-27-2026 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.85 | 1.87 |
| Revenue | $3,373,226,000.00 | ★ $4,092,400,000.00 |
| Revenue This Year | $17.63 | $6.66 |
| Revenue Next Year | $11.43 | $5.54 |
| P/E Ratio | ★ $23.20 | $43.18 |
| Revenue Growth | ★ 20.37 | 5.06 |
| 52 Week Low | $33.29 | $61.78 |
| 52 Week High | $112.74 | $100.47 |
| Indicator | NXT | COO |
|---|---|---|
| Relative Strength Index (RSI) | 50.66 | 67.12 |
| Support Level | $86.58 | $77.64 |
| Resistance Level | $91.45 | $89.83 |
| Average True Range (ATR) | 4.34 | 2.63 |
| MACD | -0.02 | 0.40 |
| Stochastic Oscillator | 77.87 | 55.03 |
Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.